tradingkey.logo

Prenetics Global Ltd

PRENW
0.020USD
+0.003+14.29%
Fechamento 11/07, 16:00ETCotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM

Prenetics Global Ltd

0.020
+0.003+14.29%

Mais detalhes de Prenetics Global Ltd Empresa

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Informações de Prenetics Global Ltd

Código da empresaPRENW
Nome da EmpresaPrenetics Global Ltd
Data de listagemJul 06, 2021
CEOMr. Joel Neoh
Número de funcionários- -
Tipo de títulosCompany Warrant
Fim do ano fiscal- -
EndereçoUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Cidade
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísHong Kong
Código postal- -
Telefone85222109588
Sitehttps://ir.prenetics.com/
Código da empresaPRENW
Data de listagemJul 06, 2021
CEOMr. Joel Neoh

Executivos da empresa Prenetics Global Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Ms. Samantha Kwok
Ms. Samantha Kwok
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Outro
100.00%
Investidores
Investidores
Proporção
Outro
100.00%
Tipos de investidores
Investidores
Proporção
Outro
100.00%

Participação acionária institucional

Atualizado em: dom, 5 de out
Atualizado em: dom, 5 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
30
3.64M
0.00%
-694.89K
2025Q2
30
3.29M
0.00%
-1.80M
2025Q1
31
3.30M
0.00%
-1.97M
2024Q4
34
4.00M
0.00%
-742.40K
2024Q3
37
3.17M
0.00%
-3.22M
2024Q2
39
4.52M
0.00%
-1.61M
2024Q1
39
4.73M
0.00%
-1.56M
2023Q4
39
5.08M
0.00%
-1.26M
2023Q3
38
5.18M
0.00%
-1.17M
2023Q2
36
5.20M
0.00%
-1.29M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Virtu Americas LLC
19.38K
0%
+19.38K
--
Jun 30, 2025
LMR Partners LLP
1.30M
0%
--
--
Jun 30, 2025
Aspex Management (HK) Limited
1.17M
0%
--
--
Jun 30, 2025
Calamos Advisors LLC
200.00K
0%
--
--
Jun 30, 2025
Walleye Capital LLC
91.75K
0%
-68.55K
-42.76%
Jun 30, 2025
D. E. Shaw & Co., L.P.
104.52K
0%
--
--
Jun 30, 2025
Jane Street Capital, L.L.C.
82.65K
0%
--
--
Jun 30, 2025
Peak6 Capital Management LLC
66.67K
0%
--
--
Jun 30, 2025
Vestcor Inc
66.67K
0%
--
--
Jun 30, 2025
Maso Capital Partners Limited
49.02K
0%
--
--
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI